Table 5 HPLC results for Partner medicines (PM)

Amodiaquine^a

n (%)

28 (25.2)

64 (57.7)

19 (17.1)

111 (100.0)

Median (IQR)

80.6 (72.6–82.9)

92.7 (88.3–97.2)

118.8 (117.2–121.4)

92.0 (84.9–101.7)

Lumefantrine^b

n (%)

4 (3.0)

120 (89.6)

10 (7.5)

134 (100.0)

Median (IQR)

83.3 (77.4–84.4)

99.4 (93.2–105.0)

117.6 (116.2–118.5)

100.3 (93.1–107.1)

Piperaquine^c

n (%)

0 (0.0)

3 (33.3)

6 (66.7)

9 (100.0)

Median (IQR)

0

112.1 (111.5–114.7)

121.1 (117.5–123.8)

117.5 (114.7–121.7)

Combined

n (%)

32 (12.6)

187 (73.6)

35 (13.8)

254 (100.0)

Median (IQR)

81.4 (72.8–83.0)

96.6 (91.6–103.4)

118.7 (117.2–120.7)

96.8 (88.9–108.4)